INTERNATIONAL PATENT: PRELUDE THERAPEUTICS INCORPORATED FILES APPLICATION FOR "JAK2 INHIBITORS AND THEIR USE AS PHARMACEUTICALS"

GENEVA, Nov. 26 -- PRELUDE THERAPEUTICS INCORPORATED (175 Innovation BoulevardWilmington, Delaware 19805) filed a patent application (PCT/US2025/029716) for "JAK2 INHIBITORS AND THEIR USE AS PHARMACEUTICALS" on May 16, 2025. With publication no. WO/2025/240835, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Xiaowei (1011 Cloister Road, Apartment AWilmington, Delaware 19809), COMBS, Andrew (939 Wawaset RoadKennett Square, Pennsylvania 19348), ROSE, John (10 Sherin DriveNewark, Delaware 19702), MEI, Song (151 Monet Cir...